LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 868 | 683 | 3556 | 0.1921 | -0.1122 |
MCF 10A | PHA-665752 | 10 | uM | LJP5 | 72 | hr | 513 | 684 | 10362 | 0.0661 | 0.0614 |
Hs 578T | A443654 | 10 | uM | LJP6 | 72 | hr | 929 | 684 | 3216 | 0.2125 | -0.1579 |
MCF 10A | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 513 | 685 | 10362 | 0.0662 | 0.0689 |
MCF 10A | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 513 | 687 | 10473 | 0.0656 | 0.0682 |
SK-BR-3 | Geldanamycin | 10 | uM | LJP6 | 72 | hr | 1476 | 688 | 3643 | 0.1889 | -0.4449 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 513 | 690 | 10473 | 0.0659 | 0.0694 |
MDA-MB-231 | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 868 | 692 | 3556 | 0.1945 | -0.1062 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 513 | 692 | 10473 | 0.0661 | 0.0704 |
MCF7 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 694 | 4056 | 0.1712 | -0.2854 |
MCF 10A | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 513 | 694 | 10362 | 0.0670 | 0.0708 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 694 | 10473 | 0.0663 | 0.0714 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 868 | 695 | 3410 | 0.2044 | -0.1065 |
Hs 578T | Foretinib | 10 | uM | LJP5 | 72 | hr | 929 | 697 | 3237 | 0.2153 | -0.1489 |
MDA-MB-231 | NVP-TAE684 | 10 | uM | LJP6 | 72 | hr | 868 | 698 | 3556 | 0.1964 | -0.1017 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 513 | 701 | 10473 | 0.0669 | 0.0735 |
MCF7 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1235 | 701 | 4056 | 0.1733 | -0.2817 |
MCF 10A | GW843682X | 10 | uM | LJP6 | 72 | hr | 513 | 701 | 10473 | 0.0669 | 0.0723 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 513 | 704 | 10473 | 0.0672 | 0.0750 |
MCF 10A | Pictilisib | 10 | uM | LJP6 | 72 | hr | 513 | 704 | 10473 | 0.0672 | 0.0740 |
MDA-MB-231 | SB590885 | 10 | uM | LJP5 | 72 | hr | 868 | 706 | 3410 | 0.2069 | -0.1008 |
MCF7 | Seliciclib | 10 | uM | LJP5 | 72 | hr | 1235 | 706 | 4267 | 0.1657 | -0.2687 |
MCF 10A | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 712 | 10362 | 0.0688 | 0.0762 |
MDA-MB-231 | Pelitinib | 10 | uM | LJP5 | 72 | hr | 868 | 713 | 3410 | 0.2091 | -0.0953 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 513 | 714 | 10473 | 0.0682 | 0.0784 |